老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Enlivex Therapeutics Ltd.

0.8886
+0.06868.37%
盘后：0.8700-0.0186-2.09%17:53 EDT
成交量：180.29万
成交额：154.75万
市值：2.11亿
市盈率：0.03
高：0.8982
开：0.8196
低：0.8000
收：0.8200
52周最高：2.10
52周最低：0.6600
股本：2.37亿
流通股本：2.35亿
量比：2.71
换手率：0.77%
股息：- -
股息率：- -
每股收益(TTM):25.48
每股收益(LYR):25.48
净资产收益率：126.17%
总资产收益率：-0.80%
市净率：0.11
市盈率(LYR):0.03

数据加载中...

总览公司新闻资讯公告
2020/02/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/31

SEC问询函

CORRESP [Cover] - Correspondence
2020/01/31

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/01/23

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/09/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/05

SEC问询函

[Cover]Correspondence
2019/06/27

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/06/26

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/06/26

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/06/19

SEC问询函

[Cover]Correspondence
更多